(Q34515522)

2 August 2017

1 reference

title

Amiodarone -- waxed and waned and waxed again (English)

1 reference

2 August 2017

1 reference

Doggrell SA

1

1 reference

PubMed ID

11825323

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Expert Opinion on Pharmacotherapy

2 August 2017

1 reference

2 August 2017

2

1 reference

2 August 2017

11

1 reference

2 August 2017

1877-1890

1 reference

Cellular electropharmacology of amiodarone

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Inhibitory effect of amiodarone on Na(+)/Ca(2+) exchange current in guinea-pig cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

21 January 2018

Intravenous amiodarone

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Bioavailability of amiodarone tablets administered with and without food in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Dramatic inhibition of amiodarone metabolism induced by grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficac

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1877

10.1517/14656566.2.11.1877

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11825323